FDA approves Mylan Pharma Tacrolimus capsules
Tacrolimus capsules is an immunosuppressant. It blocks the action of certain blood cells (eg, T lymphocytes) that can cause the body to reject the transplanted organ. Mylan Pharma’s
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
HCL and Oracle have partnered to offer a co-developed Oracle Pedigree and Serialization Manager Integration for Oracle’s E-Business Suite, leveraging HCL’s product and industry experience in systems integration.
Pilgrim claims that its integrated risk, compliance and quality management solution helps regulated organisations remain compliant, recognise and preemptively address potential operational dangers, reduce costs, and operate more